Renaissance Capital logo

2 US IPOs planned for the week of Feb 24

February 24, 2014

The following IPOs are expected to price this week:

Lumenis (LMNS), which sells laser-based systems used in surgical, ophthalmic and aesthetic procedures, plans to raise $100 million by offering 6.3 million shares at a price range of $15.00 to $17.00. At the midpoint of the proposed range, Lumenis would command a market value of $597 million. Lumenis, which was founded in 1991, booked $265 million in sales over the last 12 months. The Yokneam, Israel-based company plans to list on the NASDAQ under the symbol LMNS. Goldman Sachs, Credit Suisse and Jefferies & Co. are the joint bookrunners on the deal.

Varonis Systems (VRNS), which provides software that controls human-generated unstructured data, plans to raise $86 million by offering 4.8 million shares at a price range of $17.00 to $19.00. At the midpoint of the proposed range, Varonis Systems would command a market value of $476 million. Varonis Systems, which was founded in 2004, booked $75 million in sales over the last 12 months. The New York, NY-based company plans to list on the NASDAQ under the symbol VRNS. Morgan Stanley, Barclays, Jefferies & Co. and RBC Capital Markets are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.